{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:34:03Z","timestamp":1791952443149,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.pntd.0011795","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000}}],"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007235","name":"Colorado State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p><jats:italic>Burkholderia pseudomallei<\/jats:italic> is the causative agent of melioidosis, which is increasingly being reported worldwide. Mortality rates as high as 40% have been reported based on clinical patient outcomes in the endemic areas of Australia and Thailand. Novel therapies are needed to reduce treatment duration and adverse effects and improve treatment outcomes. Epetraborole, a novel antibiotic, targets leucyl-tRNA synthetase (LeuRS), an essential enzyme that catalyzes the attachment of leucine to transfer RNA. Epetraborole was evaluated for <jats:italic>in vitro<\/jats:italic> activity and efficacy in a murine model to assess clinical relevance against <jats:italic>Burkholderia pseudomallei<\/jats:italic> infections for possible treatment of melioidosis. Epetraborole was tested against 13 clinically derived and three reference <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic> strains that have a broad spectrum of susceptibilities to the standard-of-care (SoC) drugs for melioidosis, which showed that epetraborole exhibited minimal inhibitory concentrations of 0.25\u20134 \u03bcg\/mL. <jats:italic>Ex vivo<\/jats:italic> studies using THP-1 macrophages confirmed the potency of epetraborole and demonstrated synergy between epetraborole and ceftazidime. In the acute pulmonary murine infection model of melioidosis, epetraborole demonstrated equivalent efficacy when delivered orally or subcutaneously, which compared well with the standard-of-care drug ceftazidime. In addition, adding epetraborole to ceftazidime significantly improved antimicrobial activity in this animal model. This work warrants further exploration of epetraborole as a candidate for treating melioidosis and substantiates LeuRS as a clinically relevant drug target in <jats:italic>B<\/jats:italic>. <jats:italic>pseudomallei<\/jats:italic>.<\/jats:p>","DOI":"10.1371\/journal.pntd.0011795","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T19:23:58Z","timestamp":1701113038000},"page":"e0011795","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Epetraborole, a leucyl-tRNA synthetase inhibitor, demonstrates murine efficacy, enhancing the in vivo activity of ceftazidime against Burkholderia pseudomallei, the causative agent of melioidosis"],"prefix":"10.1371","volume":"17","author":[{"given":"Jason E.","family":"Cummings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Lunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R. K.","family":"Alley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-7277","authenticated-orcid":true,"given":"Richard A.","family":"Slayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"issue":"7","key":"pntd.0011795.ref001","first-page":"262","article-title":"A Hitherto Undescribed Infective Disease in Rangoon.","volume":"47","author":"A Whitmore","year":"1912","journal-title":"Ind Med Gaz."},{"issue":"1","key":"pntd.0011795.ref002","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.micinf.2004.08.020","article-title":"Burkholderia pseudomallei strain type, based on pulsed-field gel electrophoresis, does not determine disease presentation in melioidosis","volume":"7","author":"AC Cheng","year":"2005","journal-title":"Microbes Infect"},{"issue":"12","key":"pntd.0011795.ref003","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.3201\/eid2712.211756","article-title":"Human Melioidosis Caused by Novel Transmission of Burkholderia pseudomallei from Freshwater Home Aquarium, United States(1).","volume":"27","author":"P Dawson","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"2\u20133","key":"pntd.0011795.ref004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0001-706X(99)00066-2","article-title":"Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts","volume":"74","author":"DA Dance","year":"2000","journal-title":"Acta Trop"},{"issue":"8","key":"pntd.0011795.ref005","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1473-3099(19)30157-4","article-title":"Global burden of melioidosis in 2015: a systematic review and data synthesis","volume":"19","author":"E Birnie","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pntd.0011795.ref006","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/S1473-3099(21)00394-7","article-title":"A call to action: time to recognise melioidosis as a neglected tropical disease","volume":"22","author":"J Savelkoel","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pntd.0011795.ref007","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4269\/ajtmh.15-0405","article-title":"A Review of Melioidosis Cases in the Americas","volume":"93","author":"TJ Benoit","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pntd.0011795.ref008","doi-asserted-by":"crossref","first-page":"dlac028","DOI":"10.1093\/jacamr\/dlac028","article-title":"Improved non-redundant species screening panels for benchmarking the performance of new investigational antibacterial candidates against Category A and B priority pathogens.","volume":"4","author":"JE Cummings","year":"2022","journal-title":"JAC Antimicrob Resist."},{"issue":"4","key":"pntd.0011795.ref009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"D. Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"pntd.0011795.ref010","doi-asserted-by":"crossref","first-page":"e0005209","DOI":"10.1371\/journal.pntd.0005209","article-title":"Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response","volume":"11","author":"JE Cummings","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0011795.ref011","doi-asserted-by":"crossref","first-page":"1103297","DOI":"10.3389\/fmicb.2023.1103297","article-title":"Phenotypic and genetic alterations of Burkholderia pseudomallei in patients during relapse and persistent infections.","volume":"14","author":"R Seng","year":"2023","journal-title":"Front Microbiol."},{"key":"pntd.0011795.ref012","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis.","volume":"4","author":"WJ Wiersinga","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"pntd.0011795.ref013","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1099\/00222615-31-2-109","article-title":"Survival of Pseudomonas pseudomallei in human phagocytes","volume":"31","author":"S Pruksachartvuthi","year":"1990","journal-title":"J Med Microbiol"},{"issue":"8","key":"pntd.0011795.ref014","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1128\/AAC.48.8.2999-3005.2004","article-title":"Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods","volume":"48","author":"TJ Inglis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pntd.0011795.ref015","first-page":"1400","article-title":"Pharmacodynamics of ceftazidime\/avibactam against extracellular and intracellular forms of Pseudomonas aeruginosa","volume":"72","author":"JM Buyck","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"pntd.0011795.ref016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2149\/tmh1973.23.1","article-title":"Efficacy of antibiotics against extracellular and intracellular Burkholderia pseudomallei, and their therapeutic effects on experimental pneumonia in mice","volume":"23","author":"H Fukuhara","year":"1995","journal-title":"Japanese Journal of Tropical Medicine and Hygiene"},{"issue":"10","key":"pntd.0011795.ref017","doi-asserted-by":"crossref","first-page":"e0005065","DOI":"10.1371\/journal.pntd.0005065","article-title":"Immune Modulation as an Effective Adjunct Post-exposure Therapeutic for B. pseudomallei","volume":"10","author":"WJ Wilson","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"issue":"4","key":"pntd.0011795.ref018","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro1385","article-title":"Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei","volume":"4","author":"WJ Wiersinga","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"pntd.0011795.ref019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0036-46652006000100001","article-title":"Clinical guideline for diagnosis and management of melioidosis.","volume":"48","author":"TJ Inglis","year":"2006","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"7","key":"pntd.0011795.ref020","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.3201\/eid1407.071501","article-title":"Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei","volume":"14","author":"SJ Peacock","year":"2008","journal-title":"Emerging infectious diseases"},{"key":"pntd.0011795.ref021","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IDR.S35529","article-title":"Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection","volume":"5","author":"DS Sarovich","year":"2012","journal-title":"Infect Drug Resist"},{"issue":"4","key":"pntd.0011795.ref022","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1097-2765(03)00098-4","article-title":"Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase","volume":"11","author":"TL Lincecum","year":"2003","journal-title":"Mol Cell"},{"issue":"3","key":"pntd.0011795.ref023","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1128\/AAC.02058-12","article-title":"Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria","volume":"57","author":"V Hernandez","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pntd.0011795.ref024","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1128\/AAC.02483-12","article-title":"Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteers","volume":"57","author":"D Tenero","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0011795.ref025","first-page":"98","volume-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria.","author":"Clinical and Laboratory Standards Institute","year":"2016","edition":"3"},{"issue":"8","key":"pntd.0011795.ref026","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1128\/AAC.01803-09","article-title":"The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system","volume":"54","author":"T Mima","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"pntd.0011795.ref027"},{"issue":"2","key":"pntd.0011795.ref028","doi-asserted-by":"crossref","first-page":"dlab058","DOI":"10.1093\/jacamr\/dlab058","article-title":"TPR1, a novel rifampicin derivative, demonstrates efficacy alone and in combination with doxycycline against the NIAID Category A priority pathogen Francisella tularensis.","volume":"3","author":"JE Cummings","year":"2021","journal-title":"JAC Antimicrob Resist."},{"issue":"7878","key":"pntd.0011795.ref029","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41586-021-03899-0","article-title":"Rational design of a new antibiotic class for drug-resistant infections","volume":"597","author":"TF Durand-Reville","year":"2021","journal-title":"Nature"},{"issue":"9919","key":"pntd.0011795.ref030","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(13)61951-0","article-title":"Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial.","volume":"383","author":"P Chetchotisakd","year":"2014","journal-title":"Lancet"},{"key":"pntd.0011795.ref031","first-page":"9","article-title":"Characteristics and One Year Outcomes of Melioidosis Patients in Northeastern Thailand: A Prospective","author":"N Chantratita","year":"2023","journal-title":"Multicenter Cohort Study. Lancet Reg Health Southeast Asia"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011795","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T18:56:51Z","timestamp":1701975411000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011795"}},"subtitle":[],"editor":[{"given":"Husain","family":"Poonawala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011795","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0011795","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]}}}